-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – interferon gamma-1b in Ovarian Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Interferon gamma-1b in Ovarian Cancer Drug Details: Human interferon gamma-1b (Actimmune, Immukin, Imukin) an...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – interferon gamma-1b in Non-Small Cell Lung Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Interferon gamma-1b in Non-Small Cell Lung Cancer Drug Details: Human interferon gamma-1b (Actimmune, Immukin,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Interferon Gamma-1b in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Gamma-1b in Metastatic Breast Cancer Drug Details: Human interferon gamma-1b (Actimmune, Immukin, Imukin) an...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Interferon Gamma-1b in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Gamma-1b in Triple-Negative Breast Cancer (TNBC) Drug Details: Human interferon gamma-1b (Actimmune, Immukin, Imukin)...
-
Thematic Analysis
New![]()
Cybersecurity in Medical Devices – Thematic Intelligence
Cybersecurity remains a priority for enterprises The tech industry is experiencing significant upheaval. Big Tech has made mass layoffs to cut costs, and cybersecurity companies are not immune. However, while information technology (IT) budgets face scrutiny as companies cut discretionary spending, cybersecurity will remain a priority. Cyber risk is higher than ever, and the consequences of attacks are significant. According to Cybersecurity Ventures, global cybercrime will reach $10.5 trillion annually by 2025. Tackling this issue requires investment, and GlobalData forecasts...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Pyelonephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Pyelonephritis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Urinary Tract Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Urinary Tract Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Peritonitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Peritonitis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.